Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 243.74 billion. The enterprise value is 217.00 billion.
Market Cap | 243.74B |
Enterprise Value | 217.00B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | Jul 9, 2025 |
Share Statistics
Pfizer has 45.75 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Current Share Class | 45.75M |
Shares Outstanding | 45.75M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 17.66% |
Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 30.14 and the forward PE ratio is 32.21.
PE Ratio | 30.14 |
Forward PE | 32.21 |
PS Ratio | 10.50 |
PB Ratio | 5.78 |
P/TBV Ratio | 6.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 26.84 |
EV / Sales | 9.35 |
EV / EBITDA | 28.07 |
EV / EBIT | 30.40 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.14 |
Debt / FCF | n/a |
Interest Coverage | 74.75 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 11.13% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 14.53M |
Profits Per Employee | 5.06M |
Employee Count | 1,598 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Pfizer has paid 2.64 billion in taxes.
Income Tax | 2.64B |
Effective Tax Rate | 24.64% |
Stock Price Statistics
The stock price has decreased by -7.94% in the last 52 weeks. The beta is 0.13, so Pfizer's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | -7.94% |
50-Day Moving Average | 5,477.33 |
200-Day Moving Average | 4,889.14 |
Relative Strength Index (RSI) | 55.24 |
Average Volume (20 Days) | 39,228 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 23.22 billion and earned 8.09 billion in profits. Earnings per share was 176.76.
Revenue | 23.22B |
Gross Profit | 14.95B |
Operating Income | 7.14B |
Pretax Income | 10.73B |
Net Income | 8.09B |
EBITDA | 7.38B |
EBIT | 7.14B |
Earnings Per Share (EPS) | 176.76 |
Balance Sheet
The company has 27.83 billion in cash and 1.08 billion in debt, giving a net cash position of 26.74 billion or 584.56 per share.
Cash & Cash Equivalents | 27.83B |
Total Debt | 1.08B |
Net Cash | 26.74B |
Net Cash Per Share | 584.56 |
Equity (Book Value) | 42.17B |
Book Value Per Share | 921.88 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 64.41%, with operating and profit margins of 30.75% and 34.83%.
Gross Margin | 64.41% |
Operating Margin | 30.75% |
Pretax Margin | 46.22% |
Profit Margin | 34.83% |
EBITDA Margin | 31.81% |
EBIT Margin | 30.75% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.69%.
Dividend Per Share | 35.00 |
Dividend Yield | 0.69% |
Dividend Growth (YoY) | 371.43% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.00% |
Shareholder Yield | 0.69% |
Earnings Yield | 3.32% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |